BRCC3 Antikörper (AA 266-316)
Kurzübersicht für BRCC3 Antikörper (AA 266-316) (ABIN1977072)
Target
Alle BRCC3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 266-316
-
Spezifität
- Region between residue 266 and 316 of human BRCA1/BRCA2-containing complex subunit 36 using the numbering given in entry NP_077308.1 (GeneID 79184).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 14-316) antibody
BRCC3 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316) antibodyBRCC3 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316) antibodyBRCC3 Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal AT3B1 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316), (N-Term) antibodyBRCC3 Reaktivität: Human WB, IHC (p), EIA Wirt: Maus Monoclonal AT3B1 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) antibodyBRCC3 Reaktivität: Human WB, FACS Wirt: Kaninchen Monoclonal 25GB1580 unconjugated Recombinant Antibody
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316) antibodyBRCC3 Reaktivität: Human WB, ELISA, IF, ICC Wirt: Maus Monoclonal AT3B1 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316) antibodyBRCC3 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 36-70) antibodyBRCC3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB54401 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 18-50) antibodyBRCC3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB53911 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) antibody (FITC)BRCC3 Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Kaninchen Polyclonal FITC
-
-
Applikationshinweise
-
Approved: IF (1:250 - 1:2000), IHC, IHC-P (1:500 - 1:2000), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Ovarian Carcinoma, Prostate Carcinoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- BRCC3 (BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3))
-
Andere Bezeichnung
- BRCC3 / BRCC36
-
Hintergrund
-
Name/Gene ID: BRCC3
Synonyms: BRCC3, C6.1A, BRCC36, BRISC complex subunit BRCC36, BRCA1-A complex subunit BRCC36, CXorf53, RP11-143H17.2 -
Gen-ID
- 79184
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Target
-
